feed,title,long_url,short_url
Benzinga,Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3,https://benzinga.com/general/biotech/22/11/29641708/analysts-cut-price-targets-as-heron-therapeutics-zynrelef-disappoints-in-q3,https://bit.ly/3Tmjv4z
